Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025)

Regencell Bioscience Holdings (RGC) Property, Plant & Equipment (Net) Growth (3y) (2023 - 2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	PP&E (Net) Growth (3y) (Qtr)
1	Haleon	89.28 Bn	87.42 Bn	-	205.51%
2	Teva Pharmaceutical Industries	35.97 Bn	32.23 Bn	1.97 Bn	-11.41%
3	Zoetis	32.42 Bn	30.48 Bn	1.62 Bn	8.48%
4	Takeda Pharmaceutical	27.48 Bn	23.42 Bn	4.39 Bn	1.88%
5	United Therapeutics	22.89 Bn	20.73 Bn	648.10 Mn	27.10%
6	RedHill Biopharma	22.11 Bn	22.11 Bn	-	-
7	Viatris	20.44 Bn	18.64 Bn	1.16 Bn	-5.63%
8	Neurocrine Biosciences	17.76 Bn	16.44 Bn	800.70 Mn	13.12%
9	Elanco Animal Health	12.62 Bn	12.19 Bn	785.00 Mn	11.74%
10	Regencell Bioscience Holdings	2.86 Bn	2.86 Bn	-	-

Download Data